PUBLISHER: KBV Research | PRODUCT CODE: 1472502
PUBLISHER: KBV Research | PRODUCT CODE: 1472502
Asia Pacific Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Country and Growth Forecast, 2024 - 2031
The Asia Pacific Inhalation Capsules Market would witness market growth of 6.7% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $101.8 Million by 2031. The Japan market is registering a CAGR of 6% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.3% during (2024 - 2031).
Inhalation capsules come in various forms, including single-dose capsules and multi-dose reservoir systems. They are often used with specialized inhalation devices that help control the airflow and ensure proper dispersion of the medication. These devices may include breath-actuated mechanisms, dose counters, and other features to enhance ease of use and patient adherence. Rising technological advancements, an increase in the prevalence of respiratory diseases, rising demand for easy drug delivery methods, and the expanding utilization of inhalation therapies have all contributed to the substantial growth of the inhalation capsules market in recent years.
Additionally, increased awareness of respiratory health and disease management prompts individuals to seek appropriate treatments. Healthcare campaigns, educational programs, and advocacy efforts emphasize the importance of early detection, proper medication adherence, and lifestyle modifications. As a result, more patients are likely to opt for inhalation therapies delivered via capsules to manage their respiratory conditions effectively.
Asia-Pacific is experiencing an increase in the prevalence of chronic obstructive pulmonary disease, which is primarily attributable to smoking, air pollution, and an aging population. Countries like China, India, and Indonesia are particularly affected, as they have high levels of air pollution and a large population of smokers. Thus, the region presents lucrative growth opportunities for the market.
Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Cipla Limited
- Novartis AG
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Lonza Group Ltd. (Capsugel)
- Chiesi Farmaceutici S.p.A
- Vectura Group Plc (Philip Morris International, Inc.)
- Elpen S.A.
- Healthcaps India Ltd.
- Qualicaps Co., LTD. (Roquette Freres SA)
Asia Pacific Inhalation Capsules Market Report Segmentation
By Type
- Gelatin Capsules
- Hypromellose Capsules
By Application
- Asthma Treatment
- COPD Management
- Others
By Country
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1Asia Pacific Inhalation Capsules Market, by Type
- 1.4.2Asia Pacific Inhalation Capsules Market, by Application
- 1.4.3Asia Pacific Inhalation Capsules Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Recent Strategies Deployed in Inhalation Capsules Market
Chapter 5.Asia Pacific Inhalation Capsules Market by Type
- 5.1Asia Pacific Gelatin Capsules Market by Country
- 5.2Asia Pacific Hypromellose Capsules Market by Country
Chapter 6.Asia Pacific Inhalation Capsules Market by Application
- 6.1Asia Pacific Asthma Treatment Market by Country
- 6.2Asia Pacific COPD Management Market by Country
- 6.3Asia Pacific Others Market by Country
Chapter 7.Asia Pacific Inhalation Capsules Market by Country
- 7.1China Inhalation Capsules Market
- 7.1.1China Inhalation Capsules Market by Type
- 7.1.2China Inhalation Capsules Market by Application
- 7.2Japan Inhalation Capsules Market
- 7.2.1Japan Inhalation Capsules Market by Type
- 7.2.2Japan Inhalation Capsules Market by Application
- 7.3India Inhalation Capsules Market
- 7.3.1India Inhalation Capsules Market by Type
- 7.3.2India Inhalation Capsules Market by Application
- 7.4South Korea Inhalation Capsules Market
- 7.4.1South Korea Inhalation Capsules Market by Type
- 7.4.2South Korea Inhalation Capsules Market by Application
- 7.5Australia Inhalation Capsules Market
- 7.5.1Australia Inhalation Capsules Market by Type
- 7.5.2Australia Inhalation Capsules Market by Application
- 7.6Malaysia Inhalation Capsules Market
- 7.6.1Malaysia Inhalation Capsules Market by Type
- 7.6.2Malaysia Inhalation Capsules Market by Application
- 7.7Rest of Asia Pacific Inhalation Capsules Market
- 7.7.1Rest of Asia Pacific Inhalation Capsules Market by Type
- 7.7.2Rest of Asia Pacific Inhalation Capsules Market by Application
Chapter 8.Company Profiles
- 8.1Cipla Limited
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
- 8.2Novartis AG
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
- 8.2.5.1Trials and Approvals:
- 8.2.6SWOT Analysis
- 8.3AstraZeneca PLC
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
- 8.3.5.1Partnerships, Collaborations, and Agreements:
- 8.3.5.2Trials and Approvals:
- 8.3.6SWOT Analysis
- 8.4Boehringer Ingelheim International GmbH
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional & Segmental Analysis
- 8.4.4Research & Development Expenses
- 8.4.5SWOT Analysis
- 8.5Lonza Group Ltd. (Capsugel)
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
- 8.6Chiesi Farmaceutici S.p.A
- 8.6.1Company Overview
- 8.6.2Recent strategies and developments:
- 8.6.2.1Partnerships, Collaborations, and Agreements:
- 8.6.2.2Product Launches and Product Expansions:
- 8.6.3SWOT Analysis
- 8.7Vectura Group plc (Philip Morris International, Inc.)
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5Recent strategies and developments:
- 8.7.5.1Partnerships, Collaborations, and Agreements:
- 8.7.5.2Geographical Expansions:
- 8.7.6SWOT Analysis
- 8.8Elpen S.A.
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
- 8.9Healthcaps India Ltd.
- 8.9.1Company Overview
- 8.9.2SWOT Analysis
- 8.10.Qualicaps Co., LTD. (Roquette Freres SA)
- 8.10.1Company Overview
- 8.10.2SWOT Analysis
LIST OF TABLES
- TABLE 1Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 2Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 3Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 4Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 5Asia Pacific Gelatin Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 6Asia Pacific Gelatin Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 7Asia Pacific Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 8Asia Pacific Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 9Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 10Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 11Asia Pacific Asthma Treatment Market by Country, 2020 - 2023, USD Million
- TABLE 12Asia Pacific Asthma Treatment Market by Country, 2024 - 2031, USD Million
- TABLE 13Asia Pacific COPD Management Market by Country, 2020 - 2023, USD Million
- TABLE 14Asia Pacific COPD Management Market by Country, 2024 - 2031, USD Million
- TABLE 15Asia Pacific Others Market by Country, 2020 - 2023, USD Million
- TABLE 16Asia Pacific Others Market by Country, 2024 - 2031, USD Million
- TABLE 17Asia Pacific Inhalation Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 18Asia Pacific Inhalation Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 19China Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 20China Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 21China Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 22China Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 23China Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 24China Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 25Japan Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 26Japan Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 27Japan Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 28Japan Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 29Japan Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 30Japan Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 31India Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 32India Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 33India Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 34India Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 35India Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 36India Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 37South Korea Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 38South Korea Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 39South Korea Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 40South Korea Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 41South Korea Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 42South Korea Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 43Australia Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 44Australia Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 45Australia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 46Australia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 47Australia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 48Australia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 49Malaysia Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 50Malaysia Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 51Malaysia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 52Malaysia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 53Malaysia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 54Malaysia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 55Rest of Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 56Rest of Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 57Rest of Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 58Rest of Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 59Rest of Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 60Rest of Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 61Key Information - Cipla Limited
- TABLE 62Key Information - Novartis AG
- TABLE 63Key Information - AstraZeneca PLC
- TABLE 64Key Information - Boehringer Ingelheim International GmbH
- TABLE 65Key Information -Lonza Group Ltd.
- TABLE 66Key Information - Chiesi Farmaceutici S.p.A
- TABLE 67Key Information - Vectura Group plc
- TABLE 68Key Information - Elpen S.A.
- TABLE 69Key Information - Healthcaps India Ltd.
- TABLE 70Key Information - Qualicaps Co., LTD.
